Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity
Chloroquine and its derivatives have been used since ages to treat malaria and have also been approved by the FDA to treat autoimmune diseases. The drug employs pH-dependent inhibition of functioning and signalling of the endosome, lysosome and trans-Golgi network, immunomodulatory actions, inhibiti...
Main Authors: | Siya Kamat, Madhuree Kumari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.576093/full |
Similar Items
-
Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01) -
Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2
by: Nermeen Yosri, et al.
Published: (2021-07-01) -
Possible Beneficial Actions of Caffeine in SARS-CoV-2
by: Bianca S. Romero-Martínez, et al.
Published: (2021-05-01) -
New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
by: Bauso Luana Vittoria, et al.
Published: (2021-05-01) -
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
by: Alexander Simonis, et al.
Published: (2021-01-01)